Are you Dr. Ho?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2100 Lynn Rd
Suite 115
Thousand Oaks, CA 91360Phone+1 805-379-2322
Summary
- Dr. Pei-Ran Ho, MD is an orthopedic surgeon in Thousand Oaks, California. He is currently licensed to practice medicine in California.
Education & Training
University of California (San Francisco)Residency, Orthopaedic Surgery, 1998 - 2000
Stanford University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2026
Clinical Trials
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Start of enrollment: 2007 Feb 01
- Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- 12 citationsModeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every-4-Week Dosing to Extended-Interval DosingIh Chang, Kumar Kandadi Muralidharan, Nolan Campbell, Pei-Ran Ho
Journal of Clinical Pharmacology. 2021-03-01 - 16 citationsStatistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay.Denise Campagnolo, Qunming Dong, Lily Lee, Pei-Ran Ho, Diogo Amarante
Journal of Neurovirology. 2016-10-11 - 16 citationsNatalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head studyHelmut Butzkueven, Stephanie Licata, Douglas Jeffery, Douglas L. Arnold, Massimo Filippi
BMJ Open. 2020-10-20
